信星集團(01170.HK):公司越南一工廠暫時關閉 預計7月底復產
格隆匯7月14日丨信星集團(01170.HK)公佈,越南平陽省(集團的製造工廠所在處之一)近期爆發COVID-19疫情。根據越南廠房當地管理團隊的初步報吿,其於2021年7月10日前後發現及呈報共4例確診病例。根據當地政府部門頒佈的COVID-19應對措施,受影響廠房已由2021年7月12日起暫時關閉。受影響廠房亦已為其全體員工開展COVID-19測試。為確保工作場所衞生和安全,受影響廠房已暫時停止正常生產,以便於物業展開深層清潔和消毒。集團正與有關地方當局緊密合作,務求於受影響廠房安全地恢復正常生產,目前定於2021年7月底復產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.